Understanding the Molecular Aspects of Vitamins in Parkinson's Disease: Present-day Concepts and Perspectives.

导出原文传递

翻译打印收藏纠错

作者： Tapan,Behl ^[1] ; Piyush,Madaan ^[2] ; Aayush,Sehgal ^[3] ; Hafiz A,Makeen ^[4] ; Mohammed,Albratty ^[5] ; Hassan A,Alhazmi ^[6] ; Abdulkarim M,Meraya ^[7] ; Md Khalid,Anwer ^[8] ; Raman,Verma ^[9]

作者单位： School of Health Science and Technology, University of Petroleum and Energy Studies, Dehradun, India. ^[1] Chitkara College of Pharmacy, Chitkara University, Rajpura, Punjab, India. ^[2] GHG Khalsa College of Pharmacy, Gurusar Sadhar, Ludhiana, Punjab, India. ^[3] Pharmacy Practice Research Unit, Clinical Pharmacy Department, College of Pharmacy, Jazan University, Jazan, Saudi Arabia. ^[4] Department of Pharmaceutical Chemistry and Pharmacognosy, College of Pharmacy, Jazan University, Jazan, Saudi Arabia. ^[5] Department of Pharmaceutical Chemistry, College of Pharmacy, Jazan University, Jazan, Saudi Arabia. ^[6] Substance Abuse and Toxicology Research Centre, Jazan University, Jazan, Saudi Arabia. ^[7] Pharmacy Practice Research Unit, Department of Clinical Pharmacy, College of Pharmacy, Jazan University, Jazan, Saudi Arabia. ^[8] Department of Pharmaceutics, College of Pharmacy, Prince Sattam Bin Abdulaziz University, Alkharj, Saudi Arabia. ^[9]

关键词 Parkinson’s disease antioxidant dopaminergic levodopa neuroprotective vitamins

主题词人类(Humans);帕金森病(Parkinson Disease);维生素类(Vitamins);抗氧化剂(Antioxidants);左旋多巴(Levodopa);维生素A(Vitamin A);维生素K(Vitamin K)

DOI 10.2174/1381612829666230614145026

PMID 37317922

发布时间 2023-07-30

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交